Active form of Notch imposes T cell fate in human progenitor cells - PubMed (original) (raw)
Active form of Notch imposes T cell fate in human progenitor cells
Magda De Smedt et al. J Immunol. 2002.
Abstract
The crucial role of Notch signaling in cell fate decisions in hematopoietic lineage and T lymphocyte development has been well established in mice. Overexpression of the intracellular domain of Notch mediates signal transduction of the protein. By retroviral transduction of this constitutively active truncated intracellular domain in human CD34+ umbilical cord blood progenitor cells, we were able to show that, in coculture with the stromal MS-5 cell line, depending on the cytokines added, the differentiation toward CD19+ B lymphocytes was blocked, the differentiation toward CD14+ monocytes was inhibited, and the differentiation toward CD56+ NK cells was favored. The number of CD7+cyCD3+ cells, a phenotype similar to T/NK progenitor cells, was also markedly increased. In fetal thymus organ culture, transduced CD34+ progenitor cells from umbilical cord blood cells or from thymus consistently generated more TCR-gammadelta T cells, whereas the other T cell subpopulations were largely unaffected. Interestingly, when injected in vivo in SCID-nonobese diabetic mice, the transduced cells generated ectopically human CD4+CD8+ TCR-alphabeta cells in the bone marrow, cells that are normally only present in the thymus, and lacked B cell differentiation potential. Our results show unequivocally that, in human, Notch signaling inhibits the monocyte and B cell fate, promotes the T cell fate, and alters the normal T cell differentiation pathway compatible with a pretumoral state.
Similar articles
- Lineage divergence at the first TCR-dependent checkpoint: preferential γδ and impaired αβ T cell development in nonobese diabetic mice.
Feng N, Vegh P, Rothenberg EV, Yui MA. Feng N, et al. J Immunol. 2011 Jan 15;186(2):826-37. doi: 10.4049/jimmunol.1002630. Epub 2010 Dec 10. J Immunol. 2011. PMID: 21148803 Free PMC article. - In vitro intrathymic differentiation kinetics of human fetal liver CD34+CD38- progenitors reveals a phenotypically defined dendritic/T-NK precursor split.
Plum J, De Smedt M, Verhasselt B, Offner F, Kerre T, Vanhecke D, Leclercq G, Vandekerckhove B. Plum J, et al. J Immunol. 1999 Jan 1;162(1):60-8. J Immunol. 1999. PMID: 9886370 - In vivo and in absence of a thymus, the enforced expression of the Notch ligands delta-1 or delta-4 promotes T cell development with specific unique effects.
de La Coste A, Six E, Fazilleau N, Mascarell L, Legrand N, Mailhé MP, Cumano A, Laâbi Y, Freitas AA. de La Coste A, et al. J Immunol. 2005 Mar 1;174(5):2730-7. doi: 10.4049/jimmunol.174.5.2730. J Immunol. 2005. PMID: 15728481 - Notch signaling in T cell development.
Deftos ML, Bevan MJ. Deftos ML, et al. Curr Opin Immunol. 2000 Apr;12(2):166-72. doi: 10.1016/s0952-7915(99)00067-9. Curr Opin Immunol. 2000. PMID: 10712939 Review. - Functional development of γδ T cells.
Prinz I, Silva-Santos B, Pennington DJ. Prinz I, et al. Eur J Immunol. 2013 Aug;43(8):1988-94. doi: 10.1002/eji.201343759. Eur J Immunol. 2013. PMID: 23928962 Review.
Cited by
- Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation.
Besseyrias V, Fiorini E, Strobl LJ, Zimber-Strobl U, Dumortier A, Koch U, Arcangeli ML, Ezine S, Macdonald HR, Radtke F. Besseyrias V, et al. J Exp Med. 2007 Feb 19;204(2):331-43. doi: 10.1084/jem.20061442. Epub 2007 Jan 29. J Exp Med. 2007. PMID: 17261636 Free PMC article. - Notch dimerization is required for leukemogenesis and T-cell development.
Liu H, Chi AW, Arnett KL, Chiang MY, Xu L, Shestova O, Wang H, Li YM, Bhandoola A, Aster JC, Blacklow SC, Pear WS. Liu H, et al. Genes Dev. 2010 Nov 1;24(21):2395-407. doi: 10.1101/gad.1975210. Epub 2010 Oct 8. Genes Dev. 2010. PMID: 20935071 Free PMC article. - The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
García-Peydró M, Fuentes P, Mosquera M, García-León MJ, Alcain J, Rodríguez A, García de Miguel P, Menéndez P, Weijer K, Spits H, Scadden DT, Cuesta-Mateos C, Muñoz-Calleja C, Sánchez-Madrid F, Toribio ML. García-Peydró M, et al. J Clin Invest. 2018 Jul 2;128(7):2802-2818. doi: 10.1172/JCI92981. Epub 2018 May 21. J Clin Invest. 2018. PMID: 29781813 Free PMC article. - TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
Owens BM, Hawley TS, Spain LM, Kerkel KA, Hawley RG. Owens BM, et al. Br J Haematol. 2006 Jan;132(2):216-29. doi: 10.1111/j.1365-2141.2005.05850.x. Br J Haematol. 2006. PMID: 16398656 Free PMC article. - Engineering T Cell Development for the Next Generation of Stem Cell-Derived Immunotherapies.
Michaels YS, Durland LJ, Zandstra PW. Michaels YS, et al. GEN Biotechnol. 2023 Apr 1;2(2):106-119. doi: 10.1089/genbio.2023.0008. Epub 2023 Apr 18. GEN Biotechnol. 2023. PMID: 37928777 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials